Clinical Trials Browser

Phase 2 × Liver Neoplasms × sintilimab × Clear all

NCT06408623 2024-05-10

Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Liver Neoplasms